» Articles » PMID: 32628989

Bioactive Lipids, Inflammation and Chronic Diseases

Overview
Specialty Pharmacology
Date 2020 Jul 7
PMID 32628989
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Endogenous bioactive lipids are part of a complex network that modulates a plethora of cellular and molecular processes involved in health and disease, of which inflammation represents one of the most prominent examples. Inflammation serves as a well-conserved defence mechanism, triggered in the event of chemical, mechanical or microbial damage, that is meant to eradicate the source of damage and restore tissue function. However, excessive inflammatory signals, or impairment of pro-resolving/anti-inflammatory pathways leads to chronic inflammation, which is a hallmark of chronic pathologies. All main classes of endogenous bioactive lipids - namely eicosanoids, specialized pro-resolving lipid mediators, lysoglycerophopsholipids and endocannabinoids - have been consistently involved in the chronic inflammation that characterises pathologies such as cancer, diabetes, atherosclerosis, asthma, as well as autoimmune and neurodegenerative disorders and inflammatory bowel diseases. This review gathers the current knowledge concerning the involvement of endogenous bioactive lipids in the pathogenic processes of chronic inflammatory pathologies.

Citing Articles

Lipidomics and genomics in mental health: insights into major depressive disorder, bipolar disorder, schizophrenia, and obsessive-compulsive disorder.

Modesti M, Arena J, Del Casale A, Gentile G, Borro M, Parmigiani G Lipids Health Dis. 2025; 24(1):89.

PMID: 40069786 PMC: 11895309. DOI: 10.1186/s12944-025-02512-x.


Emerging roles of the acid sphingomyelinase/ceramide pathway in metabolic and cardiovascular diseases: Mechanistic insights and therapeutic implications.

Wang H, Wang Y, Zhang S, Bai L World J Cardiol. 2025; 17(2):102308.

PMID: 40061281 PMC: 11886385. DOI: 10.4330/wjc.v17.i2.102308.


Bioactive lipid signaling and lipidomics in macrophage polarization: Impact on inflammation and immune regulation.

Rodriguez J, Casas J, Balboa M, Balsinde J Front Immunol. 2025; 16:1550500.

PMID: 40028333 PMC: 11867965. DOI: 10.3389/fimmu.2025.1550500.


Lipids dysregulation in diseases: core concepts, targets and treatment strategies.

Dakal T, Xiao F, Bhusal C, Sabapathy P, Segal R, Chen J Lipids Health Dis. 2025; 24(1):61.

PMID: 39984909 PMC: 11843775. DOI: 10.1186/s12944-024-02425-1.


Cellular senescence: from homeostasis to pathological implications and therapeutic strategies.

Li C, Yuan Y, Jia Y, Zhou Q, Wang Q, Jiang X Front Immunol. 2025; 16:1534263.

PMID: 39963130 PMC: 11830604. DOI: 10.3389/fimmu.2025.1534263.